Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 72162-2516
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Divalproex Fig2)
Figure-3 (Divalproex Fig3)
Structure (Divalproex Str)
Label (Lbl721622516)
This is a description of an extended-release tablet containing Divalproex Sodium USP equivalent to valproic acid 500mg. It provides instructions for daily dosing, usual dosage, storage conditions, and precautions like keeping the medication out of reach of children and protecting it from light. The tablets come in a package with a QR code to access prescribing information and a Medication Guide. The tablets are manufactured by Aurobindo Pharma Limited and should be dispensed in a USP tight, light-resistant container. It also advises not to accept the tablets if the seal over the bottle opening is broken or missing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.